Sanctuary Advisors’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
Other funds holding OTLK
PA
HF
GWM
Sanctuary Advisors's OTLK Position: Q2 2026 in Review
Sanctuary Advisors opened a new position in Outlook Therapeutics (OTLK) in Q2 2026: 344,529 shares worth $548K. The stake represents ﹤0.01% of the portfolio and ranks #1912 among its holdings. This is a return to the name: Sanctuary Advisors previously reported a position in OTLK as recently as Q3 2025.
Sanctuary Advisors first reported a position in OTLK in Q2 2025 and has held it in 3 quarters since. 69 funds tracked by Wall St. Rank hold OTLK as of Q2 2026.
- Sanctuary Advisors held 344,529 shares of Outlook Therapeutics worth $548K as of Q2 2026.
- Outlook Therapeutics was a new Sanctuary Advisors position in Q2 2026.
- Outlook Therapeutics made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1912 holding.
- Sanctuary Advisors first reported a position in Outlook Therapeutics in Q2 2025 and has held it in 3 quarters since.
- 69 funds tracked by Wall St. Rank held Outlook Therapeutics as of Q2 2026.
Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.